Literature DB >> 26678624

Autophagy during cardiac remodeling.

Kazuhiko Nishida1, Kinya Otsu2.   

Abstract

Despite progress in cardiovascular research and evidence-based therapies, heart failure is a leading cause of morbidity and mortality in industrialized countries. Cardiac remodeling is a chronic maladaptive process, characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance, and arises from interactions between adaptive modifications of cardiomyocytes and negative aspects of adaptation such as cardiomyocyte death and fibrosis. Autophagy has evolved as a conserved process for bulk degradation and recycling of cytoplasmic components, such as long-lived proteins and organelles. Accumulating evidence demonstrates that autophagy plays an essential role in cardiac remodeling to maintain cardiac function and cellular homeostasis in the heart. This review discusses some recent advances in understanding the role of autophagy during cardiac remodeling. This article is part of a Special Issue entitled: Autophagy in the Heart.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autophagy; Cardiac hypertrophy; Cardiac remodeling; Heart failure; Inflammation; Reverse remodeling

Mesh:

Year:  2015        PMID: 26678624     DOI: 10.1016/j.yjmcc.2015.12.003

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  31 in total

1.  Aspirin alleviates cardiac fibrosis in mice by inhibiting autophagy.

Authors:  Ping-Ping Liu; Hong-Hong Liu; Shu-Hong Sun; Xing-Xing Shi; Wan-Cheng Yang; Guo-Hai Su; Jing Zhao
Journal:  Acta Pharmacol Sin       Date:  2017-02-20       Impact factor: 6.150

Review 2.  Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management.

Authors:  Yingmei Zhang; Adam T Whaley-Connell; James R Sowers; Jun Ren
Journal:  Pharmacol Ther       Date:  2018-06-22       Impact factor: 12.310

3.  MMP9 inhibition increases autophagic flux in chronic heart failure.

Authors:  Shyam S Nandi; Kenichi Katsurada; Neeru M Sharma; Daniel R Anderson; Sushil K Mahata; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-16       Impact factor: 4.733

Review 4.  GPCR desensitization: Acute and prolonged phases.

Authors:  Sudarshan Rajagopal; Sudha K Shenoy
Journal:  Cell Signal       Date:  2017-01-28       Impact factor: 4.315

5.  Deficit in PINK1/PARKIN-mediated mitochondrial autophagy at late stages of dystrophic cardiomyopathy.

Authors:  Chifei Kang; Myriam A Badr; Viktoriia Kyrychenko; Eeva-Liisa Eskelinen; Natalia Shirokova
Journal:  Cardiovasc Res       Date:  2018-01-01       Impact factor: 10.787

6.  Hypoxia/reoxygenation-induced upregulation of miRNA-542-5p aggravated cardiomyocyte injury by repressing autophagy.

Authors:  Fei Wang; Xin Min; Shan-You Hu; Da-Li You; Ting-Ting Jiang; Li Wang; Xiao Wu
Journal:  Hum Cell       Date:  2021-01-04       Impact factor: 4.174

7.  Focal Adhesion Kinase-mediated Phosphorylation of Beclin1 Protein Suppresses Cardiomyocyte Autophagy and Initiates Hypertrophic Growth.

Authors:  Zhaokang Cheng; Qiang Zhu; Rachel Dee; Zachary Opheim; Christopher P Mack; Douglas M Cyr; Joan M Taylor
Journal:  J Biol Chem       Date:  2016-12-19       Impact factor: 5.157

Review 8.  Understanding the molecular mechanisms and role of autophagy in obesity.

Authors:  Tapan Behl; Aayush Sehgal; Rajni Bala; Swati Chadha
Journal:  Mol Biol Rep       Date:  2021-04-02       Impact factor: 2.316

Review 9.  Insights of Chinese medicine on ventricular remodeling: Multiple-targets, individualized-treatment.

Authors:  Dan-Cai Fan; Jian-Yong Qi; Min-Zhou Zhang
Journal:  Chin J Integr Med       Date:  2017-09-02       Impact factor: 1.978

10.  Glucocorticoids preserve the t-tubular system in ventricular cardiomyocytes by upregulation of autophagic flux.

Authors:  Thomas Seidel; Dominik J Fiegle; Tim J Baur; Anne Ritzer; Sandra Nay; Christian Heim; Michael Weyand; Hendrik Milting; Robert H Oakley; John A Cidlowski; Tilmann Volk
Journal:  Basic Res Cardiol       Date:  2019-10-31       Impact factor: 12.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.